History of suicide attempts in patients with bipolar disorder type I: socio-demographic and clinical factors, quality of life and functioning

Author(s):  
Vitor Fernandes de Almeida ◽  
Severino Bezerra-Filho ◽  
Paula Studart-Bottó ◽  
Gabriela Léda-Rego ◽  
Ivã Taiuan Fialho Silva ◽  
...  
2012 ◽  
Vol 53 (2) ◽  
pp. 125-129 ◽  
Author(s):  
Lena Nabuco de Abreu ◽  
Fabiano G. Nery ◽  
Jill M. Harkavy-Friedman ◽  
Karla Matias de Almeida ◽  
Bernardo Carramao Gomes ◽  
...  

2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
M. Mazza ◽  
D. Harnic ◽  
G. Marano ◽  
V. Catalano ◽  
L. Janiri ◽  
...  

Introdution:Our study represents a pilot evaluation about how the MOOD-SR recognizes subthreshold manifestations that may be associated with clinical symptomatology in a group of bipolar patients.Methods:At Day Hospital of Psychiatry, Policlinico “A. Gemelli”, Bipolar Disorders Unit, it has been conducted an experimental study on a heterogeneous sample of 24 patients with a diagnosis of Bipolar Disorder type I. Patients have been assessed with the MOOD-SR, a clinical self-reported interview, that is specific for the spectrum of subthreshold pathology, and with the Quality of Life (QoL), that investigates the patient's quality of life.Results:We have found that 16 patients on 24 report a score higher than 60 (68,4%). Among these, 10 female patients on 15 have a total score higer than 61 (68.75%) while 6 male patients on 9 obtain a total score higher than 60 (62,5%). However, these results have only preliminary value, further studies are needed in order to obtain a deeper evaluation.Conclusion:Spectrum manifestations are both indicator of course and response to treatment and predictive for relapse. This finding may represent an important preventive instrument for maniacal relapse in patients with Bipolar Disorder, that is often underdiagnosed or confused for Unipolar Depression. By adequately recognizing the problem we will be able to refine diagnosis and individualize therapy.


2010 ◽  
Vol 32 (2) ◽  
pp. 200-201 ◽  
Author(s):  
Cristiana Castanho de Almeida Rocca ◽  
Luciana Gerchmann ◽  
Lena Nabuco de Abreu ◽  
Beny Lafer

2020 ◽  
Author(s):  
Lucas Anyayo ◽  
Scholastic Ashaba ◽  
Mark Mohan Kaggwa ◽  
Maling Samuel ◽  
Etheldreda Nakimuli-Mpungu

Abstract Background: Bipolar disorder is a psychiatric disorder that alters mood and affects over 55 million people globally with an estimated lifetime prevalence of approximately 0.8 - 1.1%. In Africa, the lifetime prevalence of the bipolar spectrum disorders is slightly lower at 0.1 – 0.6%. Bipolar disorder is ranked the sixth leading cause of disability with high rates of morbidity and mortality and negatively impacts quality of life of those affected. Methods: The aim of the study was to determine the health-related quality of life of patients with bipolar disorder attending a mental health clinic in south western Uganda. We enrolled a consecutive sample of 169 participants and evaluated their health-related quality of life using the medical outcomes health survey short form-36 (SF-36) scale. We used bivariate and multivariable logistic regression to determine associations between quality of life, sociodemographic and clinical factors setting the physical and mental component categories of quality life scale as the main outcome variables. Results: The mean age of the participants was 37.23 (12.83) and slightly over half (54.4%) were females. More than half (66.86%) of the participants had poor physical component summary (mean=45.06, SD=8.44) while 81% of the participants had poor mental component summary (mean=41.95, SD=8.45). Poor physical quality of life had a statistically significant association with history of suicidal thoughts (OR=2.75, 95% CI=1.14-6.63, P=0.02), while poor mental quality of life had a statistically significant association with history of suicidal thoughts (OR=3.94, CI=1.22-12.71, P=0.02) and history of psychotic symptoms (OR=2.46, CI=1.07-5.64, P=0.03). Conclusion: The mental and physical quality of life of our participants was poor and history of suicidal thoughts and psychotic symptoms were associated with poor quality of life. There is need to address psychotic symptoms and suicidal thoughts in the management of patients with bipolar disorder to improve health related outcomes and quality of life.


2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Lucas Anyayo ◽  
Scholastic Ashaba ◽  
Mark Mohan Kaggwa ◽  
Samuel Maling ◽  
Etheldreda Nakimuli-Mpungu

Abstract Background Bipolar disorder is a psychiatric disorder that alters mood and affects over 55 million people globally with an estimated lifetime prevalence of approximately 0.8–1.1%. In Africa, the lifetime prevalence of the bipolar spectrum disorders is slightly lower at 0.1–0.6%. Bipolar disorder is ranked the sixth leading cause of disability with high rates of morbidity and mortality and negatively impacts quality of life of those affected. Methods The aim of the study was to determine the health-related quality of life of patients with bipolar disorder attending a mental health clinic in south western Uganda. We enrolled a consecutive sample of 169 participants and evaluated their health-related quality of life using the medical outcomes health survey short form-36 (SF-36) scale. We used bivariate and multivariable logistic regression to determine associations between quality of life, sociodemographic and clinical factors setting the physical and mental component categories of quality life scale as the main outcome variables. Results The mean age of the participants was 37.23 (12.83) and slightly over half (54.4%) were females. More than half (66.86%) of the participants had poor physical component summary (mean = 45.06, SD = 8.44) while 81% of the participants had poor mental component summary (mean = 41.95, SD = 8.45). Poor physical quality of life had a statistically significant association with history of suicidal thoughts (OR = 2.75, 95% CI = 1.14–6.63, P = 0.02), while poor mental quality of life had a statistically significant association with history of suicidal thoughts (OR = 3.94, CI = 1.22–12.71, P = 0.02) and history of psychotic symptoms (OR = 2.46, CI = 1.07–5.64, P = 0.03). Conclusion The mental and physical quality of life of our participants was poor and history of suicidal thoughts and psychotic symptoms were associated with poor quality of life. There is need to address psychotic symptoms and suicidal thoughts in the management of patients with bipolar disorder to improve health related outcomes and quality of life.


2021 ◽  
Author(s):  
Lucas Anyayo ◽  
Scholastic Ashaba ◽  
Mark Mohan Kaggwa ◽  
Maling Samuel ◽  
Etheldreda Nakimuli-Mpungu

Abstract Background: Bipolar disorder is a psychiatric disorder that alters mood and affects over 55 million people globally with an estimated lifetime prevalence of approximately 0.8 - 1.1%. In Africa, the lifetime prevalence of the bipolar spectrum disorders is slightly lower at 0.1 – 0.6%. Bipolar disorder is ranked the sixth leading cause of disability with high rates of morbidity and mortality and negatively impacts quality of life of those affected. Methods: The aim of the study was to determine the health-related quality of life of patients with bipolar disorder attending a mental health clinic in south western Uganda. We enrolled a consecutive sample of 169 participants and evaluated their health-related quality of life using the medical outcomes health survey short form-36 (SF-36) scale. We used bivariate and multivariable logistic regression to determine associations between quality of life, sociodemographic and clinical factors setting the physical and mental component categories of quality life scale as the main outcome variables. Results: The mean age of the participants was 37.23 (12.83) and slightly over half (54.4%) were females. More than half (66.86%) of the participants had poor physical component summary (mean=45.06, SD=8.44) while 81% of the participants had poor mental component summary (mean=41.95, SD=8.45). Poor physical quality of life had a statistically significant association with history of suicidal thoughts (OR=2.75, 95% CI=1.14-6.63, P=0.02), while poor mental quality of life had a statistically significant association with history of suicidal thoughts (OR=3.94, CI=1.22-12.71, P=0.02) and history of psychotic symptoms (OR=2.46, CI=1.07-5.64, P=0.03).Conclusion: The mental and physical quality of life of our participants was poor and history of suicidal thoughts and psychotic symptoms were associated with poor quality of life. There is need to address psychotic symptoms and suicidal thoughts in the management of patients with bipolar disorder to improve health related outcomes and quality of life.


2020 ◽  
Author(s):  
Lucas Anyayo ◽  
Scholastic Ashaba ◽  
Mark Mohan Kaggwa ◽  
Maling Samuel ◽  
Etheldreda Nakimuli-Mpungu

Abstract Background: Bipolar disorder is a psychiatric disorder that alters mood and affects over 55 million people globally with an estimated lifetime prevalence of approximately 0.8 - 1.1%. In Africa, the lifetime prevalence of the bipolar spectrum disorders is slightly lower at 0.1 – 0.6%. Bipolar disorder is ranked the sixth leading cause of disability with high rates of morbidity and mortality and negatively impacts quality of life of those affected. Methods: The aim of the study was to determine the health-related quality of life of patients with bipolar disorder attending a mental health clinic in south western Uganda. We enrolled a consecutive sample of 169 participants and evaluated their health-related quality of life using the medical outcomes health survey short form-36 (SF-36) scale. We used bivariate and multivariable logistic regression to determine associations between quality of life, sociodemographic and clinical factors setting the physical and mental component categories of quality life scale as the main outcome variables. Results: The mean age of the participants was 37.23 (12.83) and slightly over half (54.4%) were females. More than half (66.86%) of the participants had poor physical component summary (mean=45.06, SD=8.44) while 81% of the participants had poor mental component summary (mean=41.95, SD=8.45). Poor physical quality of life had a statistically significant association with history of suicidal thoughts (OR=2.75, 95% CI=1.14-6.63, P=0.02), while poor mental quality of life had a statistically significant association with history of suicidal thoughts (OR=3.94, CI=1.22-12.71, P=0.02) and history of psychotic symptoms (OR=2.46, CI=1.07-5.64, P=0.03).Conclusion: The mental and physical quality of life of our participants was poor and history of suicidal thoughts and psychotic symptoms were associated with poor quality of life. There is need to address psychotic symptoms and suicidal thoughts in the management of patients with bipolar disorder to improve health related outcomes and quality of life.


2016 ◽  
Vol 33 (S1) ◽  
pp. S333-S334
Author(s):  
J.M. Coll ◽  
G. Martínez-Alés ◽  
N. Salgado

IntroductionHyperprolactinemia can produce clinical symptoms affecting the patient's quality of life and therefore limiting therapeutic approaches to bipolar disorder.Case reportWe report a case of a 46-year-old woman, with a 10 year history of type I bipolar disorder and a microprolactinoma, who was admitted to a psychiatry inpatient unit due to a maniac episode. Current symptoms at the moment of admission included hyperthymia, verbiage, flight of ideas and insomnia. Menstrual changes and galactorrea had been present previously. Aripiprazole was introduced, reaching a dose of 30 mg/day, in addition to her usual treatment with lithium and gabapentin. Response to treatment was good and euthymia was reached within 10 days. Moreover, gabapentin was substituted by Valproic acid, and the patient was discharged once therapeutic levels were attained. Prolactin levels were measured at the moment of admission (128.75 ng/mL) and after 11 days of treatment (92.93 ng/mL).DiscussionChoosing an adequate antipsychotic agent can reduce the risk of iatrogenesis and thus enhance adherence to treatment and quality of life. Aripiprazole had previously shown a high potential at decreasing levels of prolactine. In this case, clinical practice supports scientific evidence.ConclusionsAripiprazole is an effective treatment for type I bipolar disorder. Especially, it can be a treatment of choice in patients suffering from symptoms related to high levels of prolactine, even using a high dosage.Disclosure of interestThe authors have not supplied their declaration of competing interest.


Sign in / Sign up

Export Citation Format

Share Document